Table 3.
Gene set enrichment analysis (GSEA) of ITGA9 mRNA profiling results in HCC from the TCGA database.
| Pathway | Genes (n) | P value | Q value |
|---|---|---|---|
| Pathways in cancer | 314 | 0.0000 | 0.0627 |
| Regulation of actin cytoskeleton | 196 | 0.0000 | 0.0678 |
| Focal adhesion | 193 | 0.0000 | 0.0679 |
| Purine metabolism | 153 | 0.0000 | 0.0953 |
| Cell adhesion molecules cams | 128 | 0.0000 | 0.0574 |
| Lysosome | 121 | 0.0000 | 0.0752 |
| Pyrimidine metabolism | 97 | 0.0000 | 0.0645 |
| ECM receptor interaction | 83 | 0.0000 | 0.0758 |
| Arrhythmogenic right ventricular cardiomyopathy | 68 | 0.0000 | 0.0576 |
| Non-small-cell lung cancer | 53 | 0.0000 | 0.0687 |
| Vasopressin-regulated water reabsorption | 41 | 0.0000 | 0.0610 |
| Prostate cancer | 87 | 0.0019 | 0.0712 |
| Small-cell lung cancer | 84 | 0.0020 | 0.0639 |
| PPAR signaling pathway | 65 | 0.0020 | 0.0636 |
| Chemokine signaling pathway | 181 | 0.0020 | 0.0701 |
| Leukocyte transendothelial migration | 107 | 0.0020 | 0.0583 |
| Basal cell carcinoma | 54 | 0.0020 | 0.0657 |
| Valine leucine and isoleucine degradation | 44 | 0.0038 | 0.0632 |
| Hedgehog signaling pathway | 54 | 0.0039 | 0.0602 |
| Inositol phosphate metabolism | 54 | 0.0040 | 0.0664 |